{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T23:40:54Z","timestamp":1648683654725},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.euroneuro.2013.05.003","type":"journal-article","created":{"date-parts":[[2013,6,16]],"date-time":"2013-06-16T01:46:35Z","timestamp":1371347195000},"page":"1-4","source":"Crossref","is-referenced-by-count":2,"title":["New definition of addiction proposed by the American Society of Addiction Medicine: Which implications for the treatment of tobacco dependence?"],"prefix":"10.1016","volume":"24","author":[{"given":"Filippo","family":"Caraci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Drago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2013.05.003_bib1","article-title":"A prospective cohort study challenging the effectiveness of population-based medical intervention for smoking cessation","author":"Alpert","year":"2012","journal-title":"Tob. Control"},{"key":"10.1016\/j.euroneuro.2013.05.003_bib2","unstructured":"American Society of Addiction Medicine (ASAM), 2011a. Public Policy Statement: Definition of Addiction. Available from: \u3008http:\/\/www.asam.org\/advocacy\/find-a-policy-statement\/view-policy-statement\/public-policy-statements\/2011\/12\/15\/the-definition-of-addiction\u3009."},{"key":"10.1016\/j.euroneuro.2013.05.003_bib3","unstructured":"American Society of Addiction Medicine (ASAM), 2011b. Public Policy Statement: Long Definition of Addiction. Available from: \u3008http:\/\/www.asam.org\/docs\/publicy-policy-statements\/1definition_of_addiction_long_4-11.pdf?sfvrsn=2\u3009."},{"key":"10.1016\/j.euroneuro.2013.05.003_bib4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1360-0443.2011.03657.x","article-title":"DSM criteria for tobacco use disorder and tobacco withdrawal: a critique and proposed revisions for DSM-5","volume":"107","author":"Baker","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.euroneuro.2013.05.003_bib5","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1080\/14622200412331324965","article-title":"The neurobiology of tobacco dependence: a preclinical perspective on the role of the dopamine projections to the nucleus accumbens","volume":"6","author":"Balfour","year":"2004","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.euroneuro.2013.05.003_bib6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/ntr\/ntq222","article-title":"One-year outcomes and a cost-effectiveness analysis for smokers accessing group-based and pharmacy-led cessation services","volume":"13","author":"Bauld","year":"2011","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.euroneuro.2013.05.003_bib7","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2008.01.015","article-title":"Neurobiology of nicotine addiction: implications for smoking cessation treatment","volume":"121","author":"Benowitz","year":"2008","journal-title":"Am. J. Med."},{"key":"10.1016\/j.euroneuro.2013.05.003_bib8","doi-asserted-by":"crossref","first-page":"e1000216","DOI":"10.1371\/journal.pmed.1000216","article-title":"The global research neglect of unassisted smoking cessation: causes and consequences","author":"Chapman","year":"2010","journal-title":"PLoS Med."},{"key":"10.1016\/j.euroneuro.2013.05.003_bib9","doi-asserted-by":"crossref","first-page":"d5008","DOI":"10.1136\/bmj.d5008","article-title":"Tar wars over smoking cessation","volume":"343","author":"Chapman","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.euroneuro.2013.05.003_bib10","doi-asserted-by":"crossref","first-page":"e1732","DOI":"10.1136\/bmj.e1732","article-title":"Smoking cessation strategies","volume":"344","author":"Chapman","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.euroneuro.2013.05.003_bib11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/tc.2005.011551","article-title":"Cost-effectiveness of pharmacotherapies for nicotine dependence in primary care settings: a multinational comparison","volume":"15","author":"Cornuz","year":"2006","journal-title":"Tob. Control."},{"key":"10.1016\/j.euroneuro.2013.05.003_bib12","unstructured":"Eichenberger, I., 2011. Tobacco ruling has a financial side. August 15 2011. Available from: \u3008http:\/\/www.swissinfo.ch\/eng\/swiss_news\/Tobacco_ruling_has_a_financial_side.html?cid=30904316\u3009."},{"key":"10.1016\/j.euroneuro.2013.05.003_bib13","doi-asserted-by":"crossref","first-page":"e1696","DOI":"10.1136\/bmj.e1696","article-title":"Effect of offering different levels of support and free nicotine replacement therapy via an English national telephone quitline: randomized controlled trial","volume":"344","author":"Ferguson","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.euroneuro.2013.05.003_bib14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.drugalcdep.2009.12.021","article-title":"Mechanisms of change in extended cognitive behavioral treatment for tobacco dependence","volume":"109","author":"Hendricks","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2013.05.003_bib15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jsat.2008.11.006","article-title":"Treatment seeking for smoking cessation among young adults","volume":"37","author":"Hughes","year":"2009","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.euroneuro.2013.05.003_bib16","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1111\/j.1360-0443.2006.01578.x","article-title":"A randomized controlled trial to assess the effects of reimbursing the costs of smoking cessation therapy on sustained abstinence","volume":"101","author":"Kaper","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.euroneuro.2013.05.003_bib17","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.2105\/AJPH.2005.083527","article-title":"Factors associated with successful smoking cessation in the United States, 2000","volume":"97","author":"Lee","year":"2007","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.euroneuro.2013.05.003_bib18","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/tc.2010.038703","article-title":"How generalisable to community samples are clinical trial results for treatment of nicotine dependence: a comparison of common eligibility criteria with respondents of a large representative general population survey","volume":"20","author":"Le Strat","year":"2011","journal-title":"Tob. Control"},{"key":"10.1016\/j.euroneuro.2013.05.003_bib19","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.euroneuro.2013.05.003_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1001\/archpsyc.59.2.115","article-title":"Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates","volume":"59","author":"Narrow","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.05.003_bib21","article-title":"The politics of drug reimbursement in England, France and Germany","author":"Nguyen-Kim","year":"2005","journal-title":"Health Economics Letter"},{"key":"10.1016\/j.euroneuro.2013.05.003_bib22","doi-asserted-by":"crossref","first-page":"E810","DOI":"10.1503\/cmaj.101140","article-title":"Governments, pay for smoking cessation","volume":"182","author":"Penz","year":"2010","journal-title":"CMAJ"},{"key":"10.1016\/j.euroneuro.2013.05.003_bib23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.tips.2010.12.008","article-title":"Treatment of nicotine addiction: present therapeutic options and pipeline developments","volume":"32","author":"Polosa","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.euroneuro.2013.05.003_bib24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2165\/11590620-000000000-00000","article-title":"Pharmacotherapy for smoking cessation: current advances and research topics","volume":"25","author":"Raupach","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.euroneuro.2013.05.003_bib25","first-page":"CD004305","article-title":"Healthcare financing systems for increasing the use of tobacco dependence treatment","volume":"6","author":"Reda","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.euroneuro.2013.05.003_bib26","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00213-005-0250-x","article-title":"Nicotine and non nicotine factors in cigarette addiction","volume":"184","author":"Rose","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2013.05.003_bib27","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.amepre.2007.09.033","article-title":"Use of smoking-cessation treatments in the United States","volume":"34","author":"Shiffman","year":"2008","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.euroneuro.2013.05.003_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02791072.2012.662105","article-title":"The process addictions and the new ASAM definition of addiction","volume":"44","author":"Smith","year":"2012","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.euroneuro.2013.05.003_bib29","article-title":"Population impact of reimbursement for smoking cessation: a natural experiment in the Netherlands","author":"Willemsen","year":"2012","journal-title":"Addiction"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X13001478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X13001478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T07:21:33Z","timestamp":1539588093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X13001478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0924977X13001478"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2013.05.003","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}